Telix Pharmaceuticals Ltd | TLX - Selling And Administration Expenses

Telix Pharmaceuticals Ltd reported AUD59.09M in Selling and Administration Expenses for its second fiscal semester of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Selling And Administration Expenses Change
Cochlear COH:AU AUD 368.9M 13.1M
CSL CSL:AU USD 1.15B 251.7M
Integral Diagnostics Ltd IDX:AU AUD 140.53M 29M
Mayne Pharma MYX:AU AUD 92.42M 1.99M
Opthea Ltd OPT:AU USD 17.49M 945.17K
Paradigm Biopharmaceuticals Ltd PAR:AU AUD 4.65M 452.12K
Polynovo Ltd PNV:AU AUD 27.32M 7.84M
PYC Therapeutics Ltd PYC:AU AUD 2.7M 1.64M
Ramsay Health Care RHC:AU AUD 4.52B 161.9M
ResMed RMD:AU USD 211.67M 16.78M
Sonic Healthcare SHL:AU AUD 2.11B 104.21M